Clal Insurance is trading 4.02% down at ILA 27,000; no confirmed company-specific catalyst has been identified for the earlier declines.
- The weakness follows declines on October 28 and 29.
- The reported Alrov tender offer concerns Alrovβs control path and is not evidence of a direct cause for this move.
- Broader markets are under pressure, but the mixed index picture and positive financial-sector context do not clearly explain the decline.